RA
TRIB

Royce & Associates’s Trinity Biotech TRIB Stock Holding History

Royce & Associates’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,214
Closed -$1.09M – 1263
2017
Q2 		$1.09M Sell
1,214
-742
-38% -$630K 0.01% 952
2017
Q1 		$1.75M Hold
1,956
– – 0.01% 891
2016
Q4 		$2.03M Sell
1,956
-972
-33% -$1M 0.01% 821
2016
Q3 		$5.8M Sell
2,928
-2,266
-44% -$4.23M 0.04% 543
2016
Q2 		$8.84M Sell
5,194
-133
-2% -$225K 0.06% 416
2016
Q1 		$9.32M Buy
5,327
+643
+14% +$1.02M 0.06% 412
2015
Q4 		$8.26M Buy
4,684
+710
+18% +$1.26M 0.05% 467
2015
Q3 		$6.82M Buy
3,974
+512
+15% +$1.24M 0.04% 565
2015
Q2 		$9.38M Buy
3,462
+989
+40% +$2.57M 0.04% 560
2015
Q1 		$7.14M Buy
2,473
+34
+1% +$94.3K 0.03% 673
2014
Q4 		$6.41M Buy
2,439
+672
+38% +$1.74M 0.02% 727
2014
Q3 		$4.84M Hold
1,767
– – 0.02% 821
2014
Q2 		$6.1M Sell
1,767
-92
-5% -$327K 0.02% 807
2014
Q1 		$6.76M Sell
1,859
-288
-13% -$1.13M 0.02% 799
2013
Q4 		$8.1M Sell
2,147
-133
-6% -$479K 0.02% 745
2013
Q3 		$7.44M Buy
2,280
+41
+2% +$120K 0.02% 750
2013
Q2 		$5.66M Buy
+2,239
New +$5.57M 0.02% 804

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Royce & Associates's TRIB Position: Q3 2017 in Review

Royce & Associates sold out of Trinity Biotech (TRIB) in Q3 2017, closing a stake of 1,214 shares — an estimated $1.09M sold.

Royce & Associates first reported a position in TRIB in Q2 2013 and held it in 17 quarters. The position peaked at $9.38M in Q2 2015. 52 funds tracked by Wall St. Rank hold TRIB as of Q3 2017.

  • Royce & Associates reported no remaining Trinity Biotech position as of Q3 2017 after selling out during the quarter.
  • Royce & Associates sold 1,214 Trinity Biotech shares in Q3 2017, an estimated $1.09M.
  • Royce & Associates first reported a position in Trinity Biotech in Q2 2013 and held it in 17 quarters.
  • Royce & Associates's Trinity Biotech position peaked at $9.38M in Q2 2015.
  • 52 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2017.

Based on Royce & Associates's 13F filing for Q3 2017, filed 13 Nov 2017.